GSTP1 and prostate cancer: This study shows that CpG island GSTP1 methylation levels in tumour DNA at the time of RP is associated with patient prognosis in two independent prostate cancer cohorts with long‐term follow‐up clinical data (median: >15 years), but is outperformed by standard clinicopathological features in multivariable models of prostate cancer survival.